Since 2000, Pfizer Turkey has conducted 38 clinical research training programs across various Turkish cities in collaboration with universities and academics, with the approval of the Ministry of Health. Through these training programs, over 3,500 researchers have been trained, enhancing the nation’s capacity in vaccine and drug R&D. These efforts aim to elevate Türkiye’s pharmaceutical industry on the global stage while fostering opportunities for high-quality research, scientific advancement, and international recognition for Turkish scientists. The interactive event, held in November, focuses on key topics such as clinical research in Türkiye and the world, scientific and economic importance of clinical research, and AI’s role in R&D.
